“…Moreover, in the same series (8)(9)(10)(11)(12), some jaundiced patients appeared to benefit from surgery in terms of survival following resection: with a mean 3-year survival of 20% and some real survivors at 3 and 5 years (8, 11), results never obtained in the subgroup of non-resected jaundiced patients. In the present series, overall survival was better in resected jaundiced patients than in non-resected jaundiced patients (p=.001) and the 3-year overall survival rates of 19% was comparable to the overall survival of resected patients with pancreatic adenocarcinoma in whom the principle of curative R0 resection has been established.…”